Performance of DOCS Doximity | 99.1% in 12m
Compare DOCS with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Doximity with its related Sector/Index XLV
Performance Duell DOCS vs XLV
| TimeFrame | DOCS | XLV |
|---|---|---|
| 1 Week | -1.08% | 0.70% |
| 1 Month | 11.2% | -2.43% |
| 3 Months | 54.1% | 3.84% |
| 6 Months | 72.5% | 11.10% |
| 12 Months | 99.1% | 19.58% |
| YTD | 53.6% | 11.38% |
| Rel. Perf. 1m | 1.23 | |
| Rel. Perf. 3m | 3.72 | |
| Rel. Perf. 6m | 4.28 | |
| Rel. Perf. 12m | 4.74 | |
| Spearman 1m | 0.78 | -0.540 |
| Spearman 3m | 0.95 | 0.537 |
Is Doximity a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Doximity (NYSE:DOCS) is currently (October 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 75.95 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOCS as of October 2024 is 52.41. This means that DOCS is currently undervalued and has a potential upside of +19.49% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOCS as of October 2024 is 52.41. This means that DOCS is currently undervalued and has a potential upside of +19.49% (Margin of Safety).
Is DOCS a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 10
- Sell: 0
- Strong Sell: 2
Values above 0%: DOCS is performing better - Values below 0%: DOCS is underperforming
Compare DOCS with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.23% | 7.88% | 56.88% | 62.50% |
| US NASDAQ 100 | QQQ | -1.40% | 7.34% | 58.33% | 63.08% |
| US Dow Jones Industrial 30 | DIA | -2.68% | 8.47% | 58.26% | 69.80% |
| German DAX 40 | DBXD | -3.32% | 6.59% | 64.79% | 68.65% |
| UK FTSE 100 | ISFU | -1.96% | 12.16% | 61.63% | 74.91% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10.77% | -7.59% | 61.70% | 89.05% |
| Hongkong Hang Seng | HSI | 3.56% | -0.25% | 50.29% | 89.43% |
| Japan Nikkei 225 | EXX7 | -0.98% | 6.89% | 71.35% | 75.83% |
| India NIFTY 50 | INDA | -0.94% | 13.15% | 61.34% | 70.19% |
| Brasil Bovespa | EWZ | 0.89% | 16.54% | 77.32% | 98.20% |
DOCS Doximity vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.74% | 7.17% | 58.51% | 62.14% |
| Consumer Discretionary | XLY | -1.53% | 8.02% | 58.45% | 72.92% |
| Consumer Staples | XLP | -2.84% | 12.79% | 58.21% | 74.43% |
| Energy | XLE | 0.34% | 6.65% | 76.72% | 98.10% |
| Financial | XLF | -4.50% | 6.82% | 53.98% | 55.25% |
| Health Care | XLV | -1.78% | 13.64% | 61.44% | 79.51% |
| Industrial | XLI | -3.07% | 5.58% | 58.54% | 59.71% |
| Materials | XLB | -3.08% | 7.77% | 63.89% | 71.67% |
| Real Estate | XLRE | -3.27% | 12.91% | 49.44% | 63.29% |
| Technology | XLK | -1.41% | 6.89% | 58.66% | 61.73% |
| Utilities | XLU | -2.50% | 8.66% | 43.93% | 58.51% |
| Aerospace & Defense | XAR | -2.29% | 6.05% | 51.33% | 61.47% |
| Biotech | XBI | -3.36% | 13.14% | 57.37% | 53.87% |
| Homebuilder | XHB | -2.51% | 8.33% | 51.91% | 28.31% |
| Retail | XRT | -3.13% | 8.93% | 62.93% | 69.81% |
Does Doximity outperform its market, is DOCS a Sector Leader?
Yes, over the last 12 months Doximity (DOCS) made 99.09%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 19.58%.
Over the last 3 months DOCS made 54.11%, while XLV made 3.84%.
Yes, over the last 12 months Doximity (DOCS) made 99.09%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 19.58%.
Over the last 3 months DOCS made 54.11%, while XLV made 3.84%.
| Period | DOCS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 11.21% | -2.43% | 3.33% |
| 3 Months | 54.11% | 3.84% | 3.57% |
| 12 Months | 99.09% | 19.58% | 36.59% |